FROG vs PCTY

FROG presents a dichotomy between strong growth fundamentals and concerning internal sentiment. The company maintains a stable financial health profile with a Piotroski F-Score of 5/9 and a pristine balance sheet (Debt/Equity of 0.01), though it remains GAAP unprofitable with a -13.50% profit margin. While revenue growth is robust at 25.20% and earnings consistently beat estimates, the bearish insider signal (CEO/CFO selling) and a 0/100 technical trend offset the 'Strong Buy' analyst consensus. The stock is currently valued as a high-growth asset, trading at a premium P/S ratio of 10.13.

PCTY exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a very low Debt/Equity ratio of 0.12, indicating a robust balance sheet. While the stock is currently in a severe technical downtrend (down 45.2% over 1 year), it is trading at a significant discount to its growth-based intrinsic value of $125.38 and its analyst target of $166.52. The company maintains high gross margins (69.14%) and a consistent track record of earnings beats over 25 quarters. The bullish outlook is based on a valuation disconnect where strong operational performance is not yet reflected in the current share price.